Mostrando 3 resultados de: 3
Filtros aplicados
Área temáticas
Fisiología humana(3)
Enfermedades(2)
Farmacología y terapéutica(1)
Historia de América del Norte(1)
Medicina y salud(1)
Origen
scopus(3)
Non-HDL cholesterol is better than ldl-c at pbkp_redicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a venezuelan population
ArticleAbstract: Background: Non-high density lipoprotein cholesterol (non-HDL-c) has emerged as an important tool inPalabras claves:ASCVD, cholesterol, Coronary artery disease, LDL-c, Non-HDL-c, risk factorAutores:de Bravo M.C., D’Addosio R., Graterol M., Graterol R., Hoedebecke K., Lameda V., Martínez M.S., Olivar L.C., Ortega A., Ramírez P., Rastogi S., Rojas E.R., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Wilches S.Fuentes:scopusOmega-3 polyunsaturated fatty acids and cardiovascular health: a molecular view into structure and function
ReviewAbstract: Given the notorious impact of cardiovascular disease (CVD) as the current leading cause of mortalityPalabras claves:Cardiovascular disease, Docosahexaeonic acid, Eicosapentaenoic acid, Omega-3 polyunsaturated fatty acidsAutores:Calvo M.J., Chávez-Castillo M., Luzardo E., Martínez M.S., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Velasco M., Villasmil N.Fuentes:scopusSerum levels of lipoprotein(a) and its behavior in the state of Zulia: 10 Years of research
ReviewAbstract: Lipoprotein Lp(a) is considered one of the most important independent risk factors for atherosclerotPalabras claves:Cardiovascular disease, Coronary artery disease, Hormone replacement therapy, lipoprotein(a), myocardial infarction, Physical activity, risk factorAutores:Amell A., Añez-Ramos R., Arias F.B., Arráiz N., Cabrera M., Cano-Ponce C., Cruz S., González M.C., Mejías J.C., Mengual-Moreno E., Nava A., Rojas-Quintero J., Silva C., Sorell G L., Souki-Rincón A., Toledo A.C., Torres W., Torres Y., Valmore BermúdezFuentes:scopus